Schedule 13G ownership disclosure
Day One Biopharmaceuticals Inc
COMMON STOCK · CUSIP: 23954D109
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 10,097,668.36 · Class: 9.9%
- Abigail P. Johnson
Shares: 10,097,668.36 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-002695
- Form type
- SCHEDULE 13G/A
- Filer
- Day One Biopharmaceuticals, Inc.
- CIK
- CIK 1845337
- Filed
- Nov 05, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership